The Global Health Body Issues Alert Over Severe Shortage of Obesity Injections
Fewer than one in 10 patients that would benefit from obesity jabs such as Wegovy have access to them, caution the global health agency as it releases its inaugural recommendations on the medications.
Considering in excess of 1,000,000,000 individuals worldwide currently obese, it is urging increased and just access to this class of drugs.
Per estimates, in excess of 2,000,000,000 could be obese by 2030 without intervention.
"Our latest guidelines recognises that excess weight is a chronic disease that can be managed with holistic and lifelong treatment," stated its chief Tedros Adhanom Ghebreyesus.
Significant expense, constrained manufacturing, and distribution challenges are significant barriers to broad access to the jabs that can aid individuals in losing significant weight, explains the organization.
GLP-1 Therapy Shortage
Despite the present best projected scenario, the supply of GLP-1 therapies could only cover about 100 million people – fewer than 10% of eligible patients, per the health organization.
The advice calls on countries and companies to widen availability, through measures including licensing agreements.
The intellectual property rights on semaglutide – the main component of a leading brand – is set to lapse in several countries in 2026.
The Way Obesity Injections Operate
These medications replicate a natural hormone to slow digestion, curb appetite and enhance the sense of being full so people reduce food intake.
Patients commonly start to lose weight within a few weeks of starting on the weekly injections.
Research points to users may see weight return a year later of discontinuing the treatment, when their usual appetite return.
To be carrying excess weight elevates your likelihood for contracting diseases, such as type 2 diabetes, heart disease, brain attack, and specific malignancies.
Obesity concerns people in every country and was responsible for over three and a half million deaths worldwide in 2024, per the WHO.
